Oncology Mammary Tumours Flashcards
Mammary Tumours DDX
Lipomas
MCT
Soft Tissue Sarcoma
Mastits (systemic signs)(lactating bitches post partum)(hot red and painful)(use cephalosporins for E.Coli)
Abcess (systemic signs in lactating bitch, painful)(surgically drain)
Flank Mass
Lipoma
MCT
Soft Tissue Sarcoma
DIagnostic Tests
FNA ALL MASSES Serum and bloodchem (stress leukogram?) urinalysis Thoracis Radiographs (x3) Abdominal US (look at internal LNs) EXCISIONAL Biopsy + Histopathology + CHEMO
Cat and Dog mammary tumours
DOg- 50:50 benign:malignant - carncinomas common in CAUDAL GLANDS
Cats - 90% malignant - adenocarcinomas common (mulitple masses/ulcerated)
Staging Mammary Tumours
- Vascular and Lymphatic invasion = poor prognosis
- Anaplastic Carcinomas/Sarcomas = poor prognosis (less differentiation)
- Inflammatory Carcinomas (present as diffuse swelling/oedoma/pain/systemic signs)
- size
- LN involvement (palpation and abdominal US)
- Presence of distant metastasis
T=Tumour size (<3, 3-5, >5cm)
N0= No regional LN N1= metastasised to regional LN
M0= No distant metastasis M1= Distant metastasis
Surgical Standard of care for mammary tumours
- SHOULD HAVE SPAYED BEFORE 1st/2nd SEASON
- CATS SPAY BEFORE 6 MONTHS
as later gives no protective effect
CLEAN SURGERY unless its an INFLAMMATORY CARCINOMA
DOGS- excise all tumour using simplest surgery( 2-3cm margins)+ FAC chemo
CATS- unilateral mastectomy or staged bilateral mastectomy allows better wound reconstruction and healing (2nd intention healing)
FNA of metastatic sites every 3 months post op
Drains else can get SEROMAS
HINDLIMB OEDEMA will resolve itself
Systemic TX for Mammary tumours
Good for high grade tumours, metastasised, poor prognosis, Metronomic therapy for resistant tumours
Dogs- (FAC)5FU- Cyclophosphamide- Doxarubicin
Cats- Cyclophosphamide and Doxorubicin
Cause of Mammary Tumours
1Hormonal influence- oestrogen and prgesterone receptors which metastatic tumours lose
2, Over and underexpression of genes (BCRA1/2)
Risk Factors for developing Mammary Tumours
- increasing age
2 obesity - already having a benign mammary tumour
4 not spayed or spayed late (after 2.5 years)
POST-OP CARE/COMPLICATIONS
<3- will recur 30% >3cm- will recur 85% SARCOMAS the WORST poorly differentiated = 90% mortaltity LN inlvolvement increases mortalithy Fixation Ulceration
RECEPTOR PRESENCE GIVES BETTER PROGNOSIS
NOT PROGNOSTIC- site of tumour/type of surgery/no.of tumours/performing OHE at tumour excision